Treatment of advanced metastatic renal cell carcinoma with recombinant interleukin-2-based immunotherapy regimens: The restrictedness of the results should not generate disbelief!

M. Maffezzini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalCancer Journal (United States)
Issue number3
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this